MedPath

IPG-IRBESARTAN

IPG-IRBESARTAN

Approved
DIN Number

02435454

Drug Class

Human

Market Date

N/A

Company
HC

marcan pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02435454
AIG Number0131700003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09CA04 IRBESARTAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

IRBESARTANActive
Strength: 300 MG
Monograph: IRBESARTAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.